samedan logo
 
 
spacer
home > pmps > autumn 2003 > the impact of the eu clinical trials directive on the supply chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Impact of the EU Clinical Trials Directive on the Supply Chain

The European Union is about to enter a new era in the conduct of clinical trials within its jurisdiction. The vastly different range of current approaches from member states to trials are going to converge on 1st May 2004. At least that is the intention. Will we make it on time or will national differences on interpretation make it impossible? Not only that, but how will the new accession countries intending to join the EU in May 2004 fare? In both cases, only time will tell.

This article broadly highlights certain aspects of the changes to clinical supplies as demanded by the Directive (1) and encouraged by the accompanying publication of guidance in the revised Annex 13 (2) to European Good Manufacturing Practice (GMP). Readers may find that these changes already exist in many Member States' legislation, but in most countries the requirements are new.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Paul O'Connor, Head of Quality at Clinical Trial Services

Paul O'Connor graduated from the University of Ulster in 1994 with a BSc in Applied Biochemical Sciences. He has spent nine years in various pharmaceutical quality roles, first with Galen Ltd and subsequently with Clinical Trials Services. He is the Head of Quality for the organisation which is based in the UK, Pennsylvania and North Carolina. The company regularly provides clinical trial packaging, analytical and distribution services for 18 of the top 20 pharmaceutical companies. He is also one of the company's Qualified Persons and advises many overseas pharmaceutical companies, particularly those from the US and Japan, on release of their supplies into European Union countries.

spacer
Paul O'Connor
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement